Jan 5 (Reuters) - Island Pharmaceuticals Ltd ILA.AX:
FDA ADVISES IT REQUIRES ADDITIONAL TIME TO FINALISE RESPONSE TO CO'S RECENT SUBMISSION
CO HAD SOUGHT FURTHER CLARIFICATION ON GALIDESIVIR'S DEVELOPMENT PATHWAY UNDER FDA'S ANIMAL RULE
Further company coverage: ILA.AX
((Reuters.Briefs@thomsonreuters.com;))